FOXO3 and hepatocellular carcinoma: (114) suggested that downregulation of inhibitor of growth 4, which targeted the NF-κB/miR-155/FOXO3a signaling pathway, was closely associated with cancer staging, tumor size, and vascular invasion in HCC.